CHARACTERISTICS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CURRENTLY ON REMISSION, WITH ACTIVE DISEASE BUT NOT EXPERIENCING FLARE, AND THOSE EXPERIENCING FLARES IN CLINICAL PRACTICES IN EUROPE
Author(s)
Narayanan S1, Hutchings R2, Lu Y2
1Ipsos Healthcare, Columbia, MD, USA, 2Ipsos Healthcare, London, UK
OBJECTIVES: To assess the characteristics of SLE patients currently on Remission (Group-1), currently with active disease but not experiencing a flare (Group-2) and those who are experiencing flares (Group-3) in Europe (EU). METHODS: A multi-center medical chart review of adult (16-89 yrs) SLE patients was conducted in 1Q2014 among rheumatologists/internal medicine physicians in UK/France/Germany/Italy/Spain (5EU). Physicians were recruited from a geographically representative sample in each country. Approx. 5 consecutive eligible persistent active or relapse remitting SLE patients currently managed as part of usual care were identified. Physicians abstracted de-identified patient data on disease characteristics, lab values and treatment patterns. Patient disease status and humanistic burden was assessed by physician per clinical judgment & patient interaction. RESULTS: CONCLUSIONS: Over half of the SLE patients had an active disease while one-in-five were experiencing a flare in this study cohort, with significant variations observed within 5EU. Clinical and humanistic burden varied based on patient disease status, with highest burden observed among those experiencing flares.
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PSY97
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Systemic Disorders/Conditions